
### [NCIT:C7700](http://purl.obolibrary.org/obo/NCIT_C7700)
**Label:** Ovarian Adenocarcinoma

**Subclasses:** [NCIT:C7979](http://purl.obolibrary.org/obo/NCIT_C7979) (Ovarian Endometrioid Adenocarcinoma), [NCIT:C5228](http://purl.obolibrary.org/obo/NCIT_C5228) (Ovarian Cystadenocarcinoma), [NCIT:C7978](http://purl.obolibrary.org/obo/NCIT_C7978) (Ovarian Serous Cystadenocarcinoma), [NCIT:C40078](http://purl.obolibrary.org/obo/NCIT_C40078) (Ovarian Clear Cell Adenocarcinoma), [NCIT:C4026](http://purl.obolibrary.org/obo/NCIT_C4026) (Ovarian Mucinous Cystadenocarcinoma), [NCIT:C105556](http://purl.obolibrary.org/obo/NCIT_C105556) (Low Grade Ovarian Serous Adenocarcinoma), [NCIT:C40061](http://purl.obolibrary.org/obo/NCIT_C40061) (Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation), [NCIT:C5243](http://purl.obolibrary.org/obo/NCIT_C5243) (Ovarian Mucinous Adenocarcinoma), [NCIT:C105555](http://purl.obolibrary.org/obo/NCIT_C105555) (High Grade Ovarian Serous Adenocarcinoma), [NCIT:C6256](http://purl.obolibrary.org/obo/NCIT_C6256) (Ovarian Serous Surface Papillary Adenocarcinoma), [NCIT:C7980](http://purl.obolibrary.org/obo/NCIT_C7980) (Ovarian Clear Cell Cystadenocarcinoma), [NCIT:C7550](http://purl.obolibrary.org/obo/NCIT_C7550) (Ovarian Serous Adenocarcinoma), 

**Class expressions from DL-Learner:**

- Thing 53.75%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40114](http://purl.obolibrary.org/obo/NCIT_C40114) (Fallopian Tube Serous Cystadenofibroma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40112](http://purl.obolibrary.org/obo/NCIT_C40112) (Fallopian Tube Papilloma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40110](http://purl.obolibrary.org/obo/NCIT_C40110) (Borderline Fallopian Tube Endometrioid Tumor))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40108](http://purl.obolibrary.org/obo/NCIT_C40108) (Borderline Fallopian Tube Mucinous Tumor))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40107](http://purl.obolibrary.org/obo/NCIT_C40107) (Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40104](http://purl.obolibrary.org/obo/NCIT_C40104) (Fallopian Tube Transitional Cell Carcinoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40103](http://purl.obolibrary.org/obo/NCIT_C40103) (Fallopian Tube Mucinous Adenocarcinoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40093](http://purl.obolibrary.org/obo/NCIT_C40093) (Ovarian Squamous Cell Carcinoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40090](http://purl.obolibrary.org/obo/NCIT_C40090) (Ovarian Seromucinous Carcinoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40086](http://purl.obolibrary.org/obo/NCIT_C40086) (Ovarian Clear Cell Cystadenofibroma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40083](http://purl.obolibrary.org/obo/NCIT_C40083) (Borderline Ovarian Clear Cell Cystadenofibroma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40082](http://purl.obolibrary.org/obo/NCIT_C40082) (Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma))) 37.63%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C4008](http://purl.obolibrary.org/obo/NCIT_C4008) (Recurrent Gallbladder Carcinoma))) 37.63%


